264 related articles for article (PubMed ID: 12174154)
1. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia.
Visser W; Beckmann I; Knook MA; Wallenburg HC
Acta Obstet Gynecol Scand; 2002 Aug; 81(8):713-9. PubMed ID: 12174154
[TBL] [Abstract][Full Text] [Related]
2. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
Núñez-González JR; Sanabria-Vera CJ; Romero-Adrián T
Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
[TBL] [Abstract][Full Text] [Related]
3. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia.
Kupferminc MJ; Peaceman AM; Aderka D; Wallach D; Socol ML
Obstet Gynecol; 1996 Sep; 88(3):420-7. PubMed ID: 8752252
[TBL] [Abstract][Full Text] [Related]
4. Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia.
Chavarría ME; Lara-González L; García-Paleta Y; Vital-Reyes VS; Reyes A
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):157-64. PubMed ID: 17706337
[TBL] [Abstract][Full Text] [Related]
5. Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients.
George JF; Kirklin JK; Naftel DC; Bourge RC; White-Williams C; McGiffin DC; Savunen T; Everson MP
J Heart Lung Transplant; 1997 Oct; 16(10):1046-53. PubMed ID: 9361247
[TBL] [Abstract][Full Text] [Related]
6. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction?
Greer IA; Lyall F; Perera T; Boswell F; Macara LM
Obstet Gynecol; 1994 Dec; 84(6):937-40. PubMed ID: 7526306
[TBL] [Abstract][Full Text] [Related]
7. Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor alpha.
Romero R; Maymon E; Pacora P; Gomez R; Mazor M; Yoon BH; Berry SM
Am J Obstet Gynecol; 2000 Nov; 183(5):1070-7. PubMed ID: 11084543
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus.
Gattorno M; Vignola S; Barbano G; Sormani MP; Sabatini F; Buoncompagni A; Picco P; Pistoia V
J Rheumatol; 2000 Sep; 27(9):2251-5. PubMed ID: 10990243
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia.
Kupferminc MJ; Peaceman AM; Wigton TR; Rehnberg KA; Socol ML
Am J Obstet Gynecol; 1994 Jun; 170(6):1752-7; discussion 1757-9. PubMed ID: 8203436
[TBL] [Abstract][Full Text] [Related]
10. [Interaction among abnormal fatty acid oxidation, endothelial function disorder, and oxidative stress in the onset of severe preeclampsia].
Wang JL; Yang Z; Wang R; Zhu JM
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1471-5. PubMed ID: 18953853
[TBL] [Abstract][Full Text] [Related]
11. Adhesion molecules, activin and inhibin--candidates for the biochemical prediction of hypertensive diseases in pregnancy?
Hanisch CG; Pfeiffer KA; Schlebusch H; Schmolling J
Arch Gynecol Obstet; 2004 Sep; 270(2):110-5. PubMed ID: 12898146
[TBL] [Abstract][Full Text] [Related]
12. Adhesion molecules as a prognostic marker of liver cirrhosis.
Girón-González JA; Martínez-Sierra C; Rodriguez-Ramos C; Rendón P; Macías MA; Fernández-Gutiérrez C; Díaz F; Martín-Herrera L
Scand J Gastroenterol; 2005 Feb; 40(2):217-24. PubMed ID: 15764154
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum vascular cell adhesion molecule concentration during pregnancy.
Raynor BD; Parthasarathy S
J Soc Gynecol Investig; 1997; 4(2):78-80. PubMed ID: 9101465
[TBL] [Abstract][Full Text] [Related]
14. Plasma factors in severe early-onset preeclampsia do not substantially alter endothelial gene expression in vitro.
Donker RB; Asgeirsdóttir SA; Gerbens F; van Pampus MG; Kallenberg CG; te Meerman GJ; Aarnoudse JG; Molema G
J Soc Gynecol Investig; 2005 Feb; 12(2):98-106. PubMed ID: 15695104
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
Jablońska E; Kiluk M; Piotrowski L; Grabowska Z; Markiewicz W; Jablonski J
Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
[TBL] [Abstract][Full Text] [Related]
16. Soluble receptors and cytokine antagonists in human milk.
Buescher ES; Malinowska I
Pediatr Res; 1996 Dec; 40(6):839-44. PubMed ID: 8947960
[TBL] [Abstract][Full Text] [Related]
17. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction.
Molvarec A; Jermendy A; Nagy B; Kovács M; Várkonyi T; Hupuczi P; Prohászka Z; Rigó J
Clin Chim Acta; 2008 Jun; 392(1-2):52-7. PubMed ID: 18396154
[TBL] [Abstract][Full Text] [Related]
18. TNF-alpha/TNFRI in primary and immortalized first trimester cytotrophoblasts.
Knöfler M; Mösl B; Bauer S; Griesinger G; Husslein P
Placenta; 2000; 21(5-6):525-35. PubMed ID: 10940203
[TBL] [Abstract][Full Text] [Related]
19. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia.
Williams MA; Farrand A; Mittendorf R; Sorensen TK; Zingheim RW; O'Reilly GC; King IB; Zebelman AM; Luthy DA
Am J Epidemiol; 1999 Feb; 149(4):323-9. PubMed ID: 10025474
[TBL] [Abstract][Full Text] [Related]
20. Soluble TNF and IL-2 receptors in patients with breast cancer.
Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
